Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00168103|
Recruitment Status : Completed
First Posted : September 14, 2005
Results First Posted : August 24, 2010
Last Update Posted : March 31, 2015
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Double (Participant, Investigator); Primary Purpose: Treatment|
Biological: C1 Esterase Inhibitor
|Recruitment Details||This was a multinational study enrolling subjects at 36 study centers in 15 countries.|
A screening visit was performed before the subject presented with an hereditary angioedema (HAE) attack at the study center. Study entry was defined to occur with administration of study treatment.
One subject enrolled received study treatment without being randomized and is listed separately in the participant flow.